That's why we're thrilled to announce the launch of the Fanconi Cancer Foundation-AACR NextGen Grant for Transformative Cancer Research, a flagship funding opportunity in partnership with the American Association for Cancer Research (AACR).
Directory
Kevin McQueen
Board Member | MBA
Father of Sean
Kevin is CEO at CapTech Ventures, an IT management consulting firm based in Virginia. His son, Sean, was diagnosed with FA in 2000 at one-year-old. He and his wife, Lorraine, fundraise tirelessly for FARF, holding several events each year. They have raised over $1 million for FA research and family support services. Kevin also serves on the board of directors for the Big Brothers, Big Sisters Foundation.
The Latest
News & Events
In 1989, Lynn and David Frohnmayer founded the Fanconi Anemia Research Fund (FARF), determined and desperate to find a cure for their three daughters diagnosed with Fanconi anemia (FA). Since then, their vision has grown into a vibrant community of FA families, researchers, clinicians, donors, fundraisers, staff, and volunteers, all dedicated to improving outcomes for people with FA.
Research is the answer to one day making FA a treatable, manageable disease. Here, you'll discover the most recent strides in FA research and activities funded by FCF. Every quarter, we'll bring you updates on newly funded grants, ongoing projects, and significant milestones.